<DOC>
	<DOC>NCT01606670</DOC>
	<brief_summary>The primary objective of this study is to evaluate the perception of pain associated with Parkinson´s Disease in patients who receive Neupro® for the first time.</brief_summary>
	<brief_title>Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>The decision by the treating physician to treat a patient with Neupro® for the first time is made before the patient's participation in this NonInterventional Study (NIS) A Patient Data Consent form is signed and dated by the patient Male and female patients that suffer from pain associated with idiopathic Parkinson's Disease according to the physician's assessment Patients have not been treated with Rotigotine in the past</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>Neupro®</keyword>
</DOC>